Suppr超能文献

目前非酒精性脂肪性肝病治疗策略(综述)。

Current strategies for nonalcoholic fatty liver disease treatment (Review).

机构信息

Department of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning 110002, P.R. China.

出版信息

Int J Mol Med. 2024 Oct;54(4). doi: 10.3892/ijmm.2024.5412. Epub 2024 Aug 12.

Abstract

Nonalcoholic fatty liver disease (NAFLD), the most common chronic hepatic disease, has become a leading health problem worldwide. The present review summarized the methods and mechanisms to treat NAFLD, including the Mediterranean diet, physical activity and exercise, bariatric surgery and specific therapeutic agents, including statins, peroxisome proliferator‑activated receptor agonists, cenicriviroc and farnesoid X receptor agonists. Biologically active substances, such as peptides, alkaloids, polyphenolic compounds, silymarin, antibiotics, fatty acids, vitamins, probiotics, synbiotics and lamiaceae have also demonstrated actions that combat NAFLD. Considering their different mechanisms of action, combining some of them may prove an efficacious treatment for NAFLD. In this light, the present review describes recent progress and future prospects in treating NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝脏疾病,已成为全球范围内的主要健康问题。本综述总结了治疗 NAFLD 的方法和机制,包括地中海饮食、体力活动和运动、减重手术以及特定的治疗药物,如他汀类药物、过氧化物酶体增殖物激活受体激动剂、cenicriviroc 和法尼醇 X 受体激动剂。生物活性物质,如肽、生物碱、多酚化合物、水飞蓟素、抗生素、脂肪酸、维生素、益生菌、合生菌和唇形科植物,也表现出对抗 NAFLD 的作用。鉴于它们不同的作用机制,联合使用其中一些可能是治疗 NAFLD 的有效方法。有鉴于此,本综述描述了治疗 NAFLD 的最新进展和未来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/822a/11335354/8dedbefeaefb/ijmm-54-04-05412-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验